tailieunhanh - Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model

Triple-negative breast cancer (TNBC) represents an aggressive subtype with limited therapeutic options. Experimental preclinical models that recapitulate their tumors of origin can accelerate target identification, thereby potentially improving therapeutic efficacy. | Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN